Burger HG, Hale GE, Robertson DM, Dennerstein L (2007) A review of hormonal changes during the menopausal transition: focus on findings from the melbourne women’s midlife health project. Hum Reprod Update 13(6):559–565. https://doi.org/10.1093/humupd/dmm020
Article CAS PubMed Google Scholar
Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L (1995) A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21(2):103–113. https://doi.org/10.1016/0378-5122(94)00869-9
Article CAS PubMed Google Scholar
Kaunitz AM, Manson JE (2015) Management of menopausal symptoms. Obstet Gynecol 126(4):859–876. https://doi.org/10.1097/AOG.0000000000001058
Article PubMed PubMed Central Google Scholar
Pinkerton JV (2020) Hormone therapy for postmenopausal women. N Engl J Med 382(5):446–455. https://doi.org/10.1056/NEJMcp1714787
Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, Januzzi JL Jr, Scott NS, Natarajan P (2019) Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA 322(24):2411–2421. https://doi.org/10.1001/jama.2019.19191
Article PubMed PubMed Central Google Scholar
Anagnostis P, Christou K, Artzouchaltzi AM, Gkekas NK, Kosmidou N, Siolos P, Paschou SA, Potoupnis M, Kenanidis E, Tsiridis E, Lambrinoudaki I, Stevenson JC, Goulis DG (2019) Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Endocrinol 180(1):41–50. https://doi.org/10.1530/EJE-18-0602
Article CAS PubMed Google Scholar
Kattah AG, Smith CY, Gazzuola Rocca L, Grossardt BR, Garovic VD, Rocca WA (2018) CKD in patients with bilateral oophorectomy. Clin J Am Soc Nephrol 13(11):1649–1658. https://doi.org/10.2215/CJN.03990318
Article PubMed PubMed Central Google Scholar
Qian D, Wang ZF, Cheng YC, Luo R, Ge SW, Xu G (2022) Early menopause may associate with a higher risk of CKD and all-cause mortality in postmenopausal women: an analysis of NHANES, 1999–2014. Front Med (Lausanne) 9:823835. https://doi.org/10.3389/fmed.2022.823835
Kramer HM, Curhan GC, Singh A, Hemodialysis, Estrogen Levels in Postmenopausal Patients Study G (2003) Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study. Am J Kidney Dis 41(3):643–650. https://doi.org/10.1053/ajkd.2003.50126
The Hormone Therapy Position Statement of The North American Menopause Society" Advisory P (2022) The 2022 hormone therapy position statement of the North American menopause society. Menopause 29(7):767–794. https://doi.org/10.1097/GME.0000000000002028
Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S (2023) Heart disease and stroke statistics-2023 update: a report from the american heart association. Circulation 147(8):e93–e621. https://doi.org/10.1161/CIR.0000000000001123
Moreau KL, Hildreth KL, Meditz AL, Deane KD, Kohrt WM (2012) Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab 97(12):4692–4700. https://doi.org/10.1210/jc.2012-2244
Article CAS PubMed PubMed Central Google Scholar
Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340(23):1801–1811. https://doi.org/10.1056/NEJM199906103402306
Article CAS PubMed Google Scholar
Ouyang P, Michos ED, Karas RH (2006) Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol 47(9):1741–1753. https://doi.org/10.1016/j.jacc.2005.10.076
Article CAS PubMed Google Scholar
Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S (2012) Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am J Physiol Renal Physiol 303(3):F377-385. https://doi.org/10.1152/ajprenal.00354.2011
Article CAS PubMed PubMed Central Google Scholar
Satake A, Takaoka M, Nishikawa M, Yuba M, Shibata Y, Okumura K, Kitano K, Tsutsui H, Fujii K, Kobuchi S, Ohkita M, Matsumura Y (2008) Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int 73(3):308–317. https://doi.org/10.1038/sj.ki.5002690
Article CAS PubMed Google Scholar
Takaoka M, Yuba M, Fujii T, Ohkita M, Matsumura Y (2002) Oestrogen protects against ischaemic acute renal failure in rats by suppressing renal endothelin-1 overproduction. Clin Sci (Lond) 103(Suppl 48):434S-437S. https://doi.org/10.1042/CS103S434S
Article CAS PubMed Google Scholar
Kattah AG, Suarez MLG, Milic N, Kantarci K, Zeydan B, Mosley T, Turner ST, Ware EB, Kardia SLR, Garovic VD (2018) Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis. Menopause 25(6):625–634. https://doi.org/10.1097/GME.0000000000001062
Article PubMed PubMed Central Google Scholar
O’Donnell E, Goodman JM, Harvey PJ (2011) Clinical review: Cardiovascular consequences of ovarian disruption: a focus on functional hypothalamic amenorrhea in physically active women. J Clin Endocrinol Metab 96(12):3638–3648. https://doi.org/10.1210/jc.2011-1223
Article CAS PubMed Google Scholar
Wassmann S, Baumer AT, Strehlow K, van Eickels M, Grohe C, Ahlbory K, Rosen R, Bohm M, Nickenig G (2001) Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103(3):435–441. https://doi.org/10.1161/01.cir.103.3.435
Article CAS PubMed Google Scholar
Varas-Lorenzo C, Garcia-Rodriguez LA, Perez-Gutthann S, Duque-Oliart A (2000) Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation 101(22):2572–2578. https://doi.org/10.1161/01.cir.101.22.2572
Article CAS PubMed Google Scholar
Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ (2000) A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 133(12):933–941. https://doi.org/10.7326/0003-4819-133-12-200012190-00008
Article CAS PubMed Google Scholar
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333. https://doi.org/10.1001/jama.288.3.321
Article CAS PubMed Google Scholar
Gold EB (2011) The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am 38(3):425–440. https://doi.org/10.1016/j.ogc.2011.05.002
Article PubMed PubMed Central Google Scholar
Vellanki K, Hou S (2018) Menopause in CKD. Am J Kidney Dis 71(5):710–719. https://doi.org/10.1053/j.ajkd.2017.12.019
Ramesh S, Mann MC, Holroyd-Leduc JM, Wilton SB, James MT, Seely EW, Ahmed SB (2016) Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis. Menopause 23(9):1028–1037. https://doi.org/10.1097/GME.0000000000000657
Boardman HM, Hartley L, Eisinga A, Main C, Roquei Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B (2015) Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 3:CD002229. https://doi.org/10.1002/14651858.CD002229.pub4
Comments (0)